Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sutro Biopharma (STRO) Other Non Operating Income (2017 - 2018)

Sutro Biopharma (STRO) has disclosed Other Non Operating Income for 2 consecutive years, with $1.1 million as the latest value for Q4 2018.

  • Quarterly Other Non Operating Income rose 794.17% to $1.1 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $945000.0 through Dec 2018, changed N/A year-over-year, with the annual reading at $1.9 million for FY2018, 2584.42% up from the prior year.
  • Other Non Operating Income hit $1.1 million in Q4 2018 for Sutro Biopharma, up from -$68000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.1 million in Q4 2018 to a low of -$180000.0 in Q3 2017.